Alzheimer’s Disease
Advanced Fluid Biomarker Testing for Earlier, More Confident Diagnosis
Alzheimer’s Disease
Advanced Fluid Biomarker Testing for Earlier, More Confident Diagnosis
Overview
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia, accounting for 60% to 80% of cases1. The disease is defined biologically by the accumulation of β-amyloid plaques and tau neurofibrillary tangles, pathological changes that can begin fifteen to twenty years before the onset of clinical symptoms2,3.
Blood-based and CSF biomarker testing has moved from research settings into routine clinical practice. Plasma phospho-tau217 (pTau217) is now validated across more than a dozen independent immunoassay and mass-spectrometry platforms and is increasingly recognized as the front-line fluid marker for amyloid pathology9. Data presented at the 2026 Alzheimer’s Association International Conference (AAIC) further reinforce that multi-analyte reporting, combining pTau217 with markers such as Aβ42, GFAP, and neurofilament light (NfL), meaningfully reduces the proportion of diagnostically indeterminate results compared with any single analyte alone10.
CSF biomarker testing remains a well-validated alternative to amyloid PET imaging, with approximately 90% concordance between the two methods4, and real-world data presented at AAIC 2026 report comparable concordance, 91%, between blood-based biomarkers and CSF or amyloid PET in routine neurology practice11. Blood-based testing adoption is accelerating in parallel: 87% of physicians expect it to become the standard of care for AD evaluation6, and Medicare claims data presented at AAIC 2026 show confirmatory blood-based biomarker testing utilization more than doubling year over year12.
TrilliumBiO’s Alzheimer’s Disease Testing Portfolio gives clinicians a validated, CLIA-certified path to fluid biomarker testing, whether ordering the CSF panel or the full blood-based panel, supporting earlier, more confident diagnosis and more informed care planning.
7.4 Million Americans Age 65+ Are Living With Alzheimer’s Disease in 2026, Projected to Nearly Double by 2050
Physicians Estimate 1 in 5 Seniors (18%) May Have Undiagnosed AD
Globally, More Than 75% of People With Dementia Have Not Received a Formal Diagnosis
Nearly 4 in 5 Americans (79%) Want to Know if They Have Alzheimer’s Disease Before It Impacts Their Lives
87% of Physicians Expect Blood-Based Testing to Become the Standard of Care
Clinical Utility
Enhanced Diagnostic Confidence
-
- Plasma pTau217 is now validated across 15 or more independent platforms and, interpreted alongside clinical presentation and cognitive testing, supports earlier and more confident identification of AD pathology9.
- CSF biomarker testing (Aβ42, pTau181, tTau) shows approximately 90% concordance with amyloid PET,4 and real-world blood-based biomarker data presented at AAIC 2026 report comparable concordance in routine neurology practice11.
Differentiation From Other Causes of Cognitive Decline
- Multi-analyte panels combining pTau217 with GFAP and NfL help differentiate AD from vascular cognitive impairment, Parkinson’s disease, and other non-AD dementias13.
- A 2026 multicenter real-world study spanning 38 memory clinics (n=1,443) found plasma pTau217 remained a stable, reliable differentiator of AD versus non-AD neurologic disorders13.
Insight Into Disease Burden and Progression
- Multi-analyte reporting reduces the proportion of diagnostically indeterminate results compared with any single fluid marker, sharpening the clinical picture in early or borderline presentations10.
- Plasma NfL has emerged as a strong predictor of progression to non-AD dementias among patients presenting with mild cognitive impairment, supporting its inclusion in a comprehensive blood-based panel14.
Support for Longitudinal Assessment and Treatment Monitoring
- As anti-amyloid therapies become more widely used, GFAP and pTau species offer a fluid-based way to track biological response over time, complementing clinical and cognitive follow-up15.
- Serial blood-based biomarker measurement may help clinicians monitor disease trajectory and therapy response without repeat CSF collection or PET imaging15.
Alzheimer’s Disease Testing Portfolio
CSF Biomarkers
Aβ42: amyloid plaque burden, the earliest core AD pathology, seen as a drop in CSF concentration as amyloid gets sequestered into plaques
pTau181: amyloid-driven tau phosphorylation
tTau: overall intensity of neuronal injury, a general severity signal
Blood-Based Biomarkers
*Aβ42: amyloid plaque burden
APOE4: genetic risk, the strongest common genetic risk factor for late-onset AD, useful for pretest probability rather than active pathology
**GFAP: reactive astrogliosis, an early neuroinflammatory response that rises with amyloid, often before tau spreads
**NfL: general axonal injury, non-specific, best used to track progression or flag non-AD causes of decline
pTau181: amyloid-driven tau phosphorylation
*pTau217: amyloid pathology, currently the single most sensitive and specific plasma marker and the front-line screening analyte
*tTau: overall neurodegeneration severity, less specific to AD than the phosphorylated tau species
*These biomarkers were developed and their performance characteristics determined by TrilliumBiO. They have not been cleared or approved by the U.S. Food and Drug Administration.
**For Research Use Only
Mobile Phlebotomy Service:
If a blood draw is not possible in your office, you can utilize a mobile phlebotomy service, coordinated by TrilliumBiO, so patients can have their blood drawn at home, at their convenience. For more information, contact support@trilliumbio.com or call 1-888-261-2812, option 1.
Privacy Policy
This Privacy Policy describes how TrilliumBiO (“We” or “Us”) collects, uses, shares, and protects information when you interact with our affiliated sites where this Privacy Policy is posted (“the Site”).
What Information We Collect
Information you give us: We receive and store some information that you enter on our Sites or that you provide to us through the Sites.
The information we collect or that you provide on or through our Sites or by using our services includes:
- Data that may personally identify you, including your name, postal address, billing address, shipping address, e-mail address, home, work and mobile telephone numbers, age, date of birth, that may personally identify you, sex at birth, IP address, medical conditions, you may have, information related to medical conditions (collectively, “Personal Data”);
- Information that you provide by filling in forms on our Sites, such as appointment request forms or product ordering forms. It also includes information you provide when you register to use our Sites, purchase products, or use services available through the Sites or facilities. We may also ask you for information when you report a problem with our Sites. Some forms collect sensitive information, such as health information, necessary for us to provide our services to you;
- Records and copies of your correspondence (including email addresses), if you contact us;
- Your responses to surveys that we might ask you to complete for research, development, and marketing purposes; and
- Details of transactions you carry out through our Sites.
You also may provide information to be published or displayed (hereinafter, “Posted”) on public areas of the Sites or transmitted to other users of the Sites or third parties (collectively, “User Contributions”). Your User Contributions are Posted on and transmitted to others at your own risk. Although we limit access to certain pages, please be aware that no security measures are perfect or impenetrable. Additionally, we cannot control the actions of other users of the Sites with whom you may choose to share your User Contributions. Given those limitations, we cannot and do not guarantee that your User Contributions will not be viewed by unauthorized persons.
Information we collect automatically: We collect some information about you automatically as you navigate through or use our Sites. Information collected automatically may include usage details, IP addresses, session replay and recording technology (recording your movements, clicks, etc. on our Sites), and information collected through cookies, web beacons, pixels tags, and other tracking technologies. As you navigate through and interact with our Sites, we may use automatically collect certain information about your equipment, browsing actions, and patterns, specifically:
- Usage Details. Details of your visits to our Sites, such as traffic data, location, logs, referring/exit pages, date and time of your visit to or use of our Sites, error information, clickstream data, and other communication data and the resources that you access and use on or in the Sites.
- Device Information. Information about your computer, mobile device, and Internet connection, specifically your IP address, operating system, browser type, and application version information.
- Location Data. Information about your location collected through Geolocation technology. Our applications and services that run on mobile devices do not generally use geolocation. If geolocation information will be collected, we will update this Privacy Policy.
The information we collect automatically may include Personal Data or we may maintain or associate information we collect with Personal Data we collect in other ways or receive from third parties. It helps us to improve our Sites and to deliver a better and more personalized service by enabling us to:
- estimate our audience size and usage patterns;
- improve our product and services offering;
- store information about your preferences, allowing us to customize our Sites according to your individual interests; and
- recognize and/or authenticate you when you return to our Sites.
We use different forms of technology to enable our automatic collection of data. The technologies that we use for automatic collection of data may include:
- Cookies (or browser cookies). We and our service providers may use cookies, web beacons, and other technologies to receive and store certain types of information whenever you interact with our Sites, whether through your computer or mobile device. A cookie is a small file or piece of data sent from a website and stored on the hard drive of your computer or mobile device. On your computer, you may refuse to accept browser cookies by activating the appropriate setting on your browser, and you may have similar capabilities on your mobile device in the preferences for your operating system or browser. Please note that if you select this setting you may be unable to access or use certain parts of our Sites. Unless you have adjusted your browser or operating system setting so that it will refuse cookies, our system will issue cookies when you use our Website.
- Pixels and Web Beacons. We may use small electronic files known as web beacons (also referred to as clear gifs, pixel tags, and single-pixel gifs) on our Site or in communications that permit us, for example, to count users who have visited those pages or opened an e-mail and for other related Sites statistics (for example, recording the popularity of certain Sites content and verifying system and server integrity). We use this information to assist us in improving our user experience.
- Do Not Track Signals. Some web browsers permit you to broadcast a signal to websites and online services indicating a preference that they “do not track” your online activities. At this time, we do not honor such signals. However, we do not track your online activities on or across third party websites or other online services for any purpose, including advertising, unless you specifically opt-in to a program or campaign that authorizes such tracking.
Communications, Subscriptions, and Related Services
Our Sites may provide you with an opportunity to request and receive communications from us or third parties using any of the means of contact that you provide to us. You can unsubscribe from communications at any time by following the instructions in each communication or other mechanisms that we have available.
Email communications that you send to us by using an available email link on our Site may be shared with an individual that is most able to address your inquiry. We make every effort to respond in a reasonable amount of time once a communication is received. Note, that email communications that you send using the email link on our Site are not automatically encrypted, and it is possible that unencrypted email communications with us may be accessed or viewed by another internet user while in transit to us.
Surveys
We occasionally send or make available surveys to visitors of our site. The information from these surveys is used in aggregated, de-identified form to help us understand the needs of our visitors so that we can improve our Site. The information may be shared with third parties that we have a business relationship. We generally do not ask for information in surveys that would personally identify you; if we do request contact information for follow-up, you may decline to provide it. If survey respondents provide personal information (such as an email address) in a survey, it is only shared with those people who need to see it to respond to the question or request, or with third parties who perform data management services for our Site. We required those third parties to keep all data from surveys confidential.
How We Use the Information that We Collect
In addition to the uses that have already been described, we may also use the information that we collect for other purposes including:
- Optimizing the performance and user experience of our Sites;
- Operating, evaluating, and improving our business;
- Providing healthcare services;
- Delivering or installing products;
- Marketing and advertising products and services, including by inferring your interests from your interactions with our websites and newsletters and tailoring advertisements, newsletters, and offers to you (both on our websites and on other websites) based on your interactions with us in our stores and online interests;
- Sending you email newsletters;
- Conducting research and analysis;
- Communicating with you about your account, special events, and surveys; and
- Establishing and managing your accounts with us.
We may combine this information with any other information we have about you from other sources. We will use that combined data in accordance with this Privacy Policy and other agreements we might have with you.
Patient Data
We may receive information about individuals in connection with the delivery of healthcare services. Information received in the capacity of delivering a healthcare service will be directed to the United States and considered protected health information (“PHI”) as that term is defined by the Health Insurance Portability and Accountability Act of 1996 and its implementing regulations (“HIPAA”). We will interact with PHI of a patient as set forth in our Notice of Privacy Practices and as otherwise required by HIPAA. All PHI will be handled and stored in the United States and subject to HIPAA and any other applicable law.
Data Retention
We will retain your information for as long as your account is active or as needed to provide you services, comply with our legal obligations, resolve disputes, and enforce our agreements. You may request that we delete your data by contacting us as provided below. However, we may not be able to honor that request in all instances given the laws and regulations that apply to us or the nature of the information that you provide to us. For example, we may also have a legal basis or obligation to maintain medical and other information about you to provide care and treatment or to comply with our professional, legal, and other obligations.
Disclosure of Your Information
We may share the information we collect about you with third parties who we have engaged to help us provide the Site, as well as the products and services available through our Site. Your Personal Data may be disclosed to affiliates, contractors, service providers, and other third parties we use to support our business; and any authorization you have provided. The services provided by these organizations include providing IT and infrastructure support services, advertising, marketing, and payment processing services. Advertising and marketing partners may receive and use your Personal Data to assist us with our advertising and marketing efforts. In each case, we will ensure that these third parties have agreed to safeguard your data.
We may provide third parties with aggregate statistics about our visitors, traffic patterns, and related site information. These data reflect site-usage patterns gathered during visits to our website each month, but they do not contain information that personally identifies you unless you have given us permission to share that information.
We may also disclose your Personal Data:
- to a buyer or other successor in the event of a merger, divestiture, restructuring, reorganization, dissolution, or other sale or transfer of some or all of our assets, whether as a going concern or as part of bankruptcy, liquidation, or similar proceeding, in which Personal Data held by us about our Sites users are among the assets transferred;
- to fulfill the purpose for which you provide it;
- for any other purpose disclosed by us when you provide the information;
- with your consent;
- to comply with any court order, law, or legal process, including to respond to any government or regulatory request;
- to affiliates to market their products or services to you if you have purchased one of our products and if you have not opted out of these disclosures. For more information, see Choices About How We Use and Disclose Your Information;
- to enforce or apply our Terms of Use and other agreements, including for billing and collection purposes; and
- if we believe disclosure is necessary or appropriate to protect the rights, property, or safety of us, our Users or customers, or others. This includes exchanging information with other companies and organizations for the purposes of fraud protection and credit risk reduction.
Choices About How We Use and Disclose Your Information
Our sponsors and advertisers have agreed that they will not collect any personally identifiable information from our Site visitors while using our Sites; however, we do not control the use of cookies provided by other third parties, nor do we manage the information collected by other third parties. These third parties may aggregate the information they collect with information from their other customers for their own purposes and in accordance with their own respective privacy policies.
In addition, we strive to provide you with choices regarding the Personal Data you provide to us. We have created or you have available mechanisms to provide you with control over your Personal Data:
- Cookie Settings and Advertising. You can set your browser or operating system to refuse all or some cookies or to alert you when cookies are being sent. If you disable or refuse cookies, please note that some parts of our Sites may then be inaccessible or not function properly.
- Targeted Advertising. To learn more about interest-based advertisements and your opt-out rights and options, visit the Digital Advertising Alliance and the Network Advertising Initiative (NAI) websites (https://youradchoices.com/ and https://thenai.org/). Please note that if you choose to opt out, you will continue to see ads, but they will not be based on your online activity. We do not control third parties’ collection or use of your information to serve interest-based advertising. However, these third parties may provide you with ways to choose not to have your information collected or used in this way. You can also opt out of receiving targeted ads from members of the NAI on its website.
Your Rights Regarding Your Information and Accessing and Correcting Your Information
You can Contact Us through the Contact Information below to access and/or find out what information we have about you and to correct that information. You can also review and change your Personal Data by logging into our site and visiting either the Settings or Account Preferences sections, if available. You may also notify us through the Contact Information below of any changes or errors in any Personal Data we have about you to ensure that it is complete, accurate, and as current as possible or to delete your account. We cannot completely delete your personal information except by also deleting your account with us. We may not be able to accommodate your request if we believe it would violate any law or legal requirement or if we have a legal basis or obligation to maintain it, or if it would cause the information to be incorrect.
Security
We use reasonable security measures to protect the confidentiality of personal information under our control, and we appropriately limit access to it. We use a variety of information security measures to protect your online transactions with us. The Site uses encryption technology, such as Secure Sockets Layer (SSL), to protect your personal information during data transport. SSL protects information you submit via our website, such as ordering information including your name, address, and credit card number. Even with those protections, we cannot ensure or warrant the security of any information you transmit to us, and you do so at your own risk. We have taken reasonable steps to ensure the integrity and confidentiality of personally identifiable information that you may provide. You should understand, however, that electronic transmissions via the internet are not necessarily secure from interception, and so we cannot absolutely guarantee the security or confidentiality of such transmissions.
Users in the European Economic Area (EEA) or the United Kingdom
If you are a resident of the EEA or the United Kingdom, the following information applies with respect to personal data collected through your use of our Site. Purposes of Processing and Legal Basis for Processing: As already explained in this Privacy Policy, we process personal data in various ways depending upon your use of the services. We process personal data on the following legal bases: (1) with your consent; (2) as necessary to provide the services; (3) to comply with our legal obligations; and (4) as necessary for our legitimate interests in providing the services where those interests do not override your fundamental rights and freedoms related to data privacy.
Transfers: Personal data we collect may be transferred to, and stored and processed in, the United States or any other country in which we or our affiliates or processors maintain facilities. We will ensure that transfers of personal data to a country or an international organization outside the EEA or the United
Kingdom are subject to appropriate safeguards.
Individual Rights: You are entitled to the rights under Chapter III of the EU General Data Protection Regulation or the United Kingdom General Data Protection Regulations and Data Protection Act 2018 with respect to the processing of your personal data, which include the right to access and rectify and to request erasure of personal data. In order to verify your identity, we may require you to provide us with personal information prior to accessing any records containing information about you. To exercise these rights, please contact our Data Protection Officer at info@trilliumbio.com.
Complaints or Concerns: You are welcome to raise any complaints or concerns to us by contacting our Data Protection Officer at info@trilliumbio.com. You also have the right to lodge a complaint with a supervisory authority.
Protecting Children’s Privacy
Our Sites are not intended for users under 18 years of age. No one under age 18 may provide any information to or through the Sites. We do not knowingly collect Personal Data from users under 18. If you are under 18, do not use or provide any information on or in our Sites or on or through any of their features, including your name, address, telephone number, email address, or any screen name or username you may use. If we learn we have collected or received Personal Data from a user under 18 without verification of parental consent, we will delete that information. If you believe we might have any information from a user under 18, please contact us at the contact information below.
Links to Third Party Websites
Our Sites may link to other websites that have their own privacy policies. Be sure to review the privacy policy on the site you are visiting because we do not control any third party website.
Privacy Policy Updates
We may update our Privacy Policy as our operations and business evolve. If we make significant changes to this Privacy Policy, we will use reasonable efforts to provide you with advance notice, which may be done by posting a message on our Site.
Contact Information
If you have a question or concern regarding your privacy or this Privacy Policy, please contact us at info@trilliumbio.com.
Effective Date of Notice: October 1, 2024
Revised: May 11, 2026
HIPAA Information
Trillium’s Notice of Privacy Practices
This Notice Describes How Medical Information About Patients May Be Used and Disclosed And How Patients Can Get Access To This Information. This Notice of Privacy Practices applies to TrilliumBiO, LLC (“Trillium”) except to the extent that Trillium performs clinical trials tests or other services that do not involve standard electronic transactions for which the Department of Health and Human Services (“HHS”) has adopted standards.
Trillium’s Protection of Protected Health Information (PHI)
Under the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) Trillium is required by law to maintain the privacy of health information that identifies Patients, called protected health information (“PHI”), and to provide Patients with notice of our legal duties and privacy practices regarding PHI.
Trillium is committed to the protection of Patient PHI and will make reasonable efforts to ensure the confidentiality of Patient PHI as required by statute and regulation. Trillium takes this commitment seriously and will work with Patients to comply with their right to receive certain information under HIPAA.
Trillium’s Use and Disclosure of PHI
As permitted under HIPAA, the following categories explain the types of uses and disclosures of PHI that Trillium may make:
For treatment
Trillium may use or disclose PHI for treatment purposes, including disclosure to physicians, nurses, medical students, pharmacies, and other health care professionals who provide Patients with health care services or are involved in the coordination of Patient care such as providing your physician with your laboratory test results.
For payment
Trillium may use or disclose PHI to bill and collect payment for laboratory or genetic counseling services we provide.
For health care operations
Trillium may disclose PHI to other health care providers or health plans that are involved in Patient care for their health care operations.
Appointment reminders and health-related benefits and services
Trillium may use and disclose PHI to contact Patients as a reminder that they have an appointment with us and may use and disclose PHI to tell Patients about health-related benefits and services that may be of interest.
Disclosure of PHI to you
Trillium may disclose PHI to Patients or as directed by Patients to a third party.
Emergency circumstances and notifications
Trillium will attempt to obtain Patient agreement to use or disclose PHI during an emergency event to notify, or assist in the notification of a family member, Patient personal representative, or another person responsible for Patient care regarding Patient location, general condition, or death. Trillium will exercise its professional judgement based on the circumstances and use and disclose PHI for Patient safety.
Individuals involved in Patient care or payment for your care
Trillium may disclose PHI to a person who is involved in Patient care or helps pay for Patient care, such as a family member or friend. We also may notify a Patient’s family about Patient location or general condition or disclose such information to an entity assisting in a disaster relief effort. As allowed by federal and state law, we may disclose the PHI of minors to their parents or legal guardians.
Business associates
Trillium may disclose PHI to its business associates to perform certain business functions or provide certain business services to Trillium. For example, we may use another company to perform billing services on our behalf. All of our business associates are required to maintain the privacy and confidentiality of Patient PHI. In addition, at the request of your health care providers or health plan, Trillium may disclose PHI to their business associates for purposes of performing certain business functions or health care services on their behalf.
Disclosure for judicial and administrative proceedings
Under certain circumstances, Trillium may disclose Patient PHI in the course of a judicial or administrative proceeding, including in response to a court or administrative order, subpoena, discovery request, or other lawful process.
Law enforcement
Trillium may disclose PHI for law enforcement purposes, including reporting of certain types of wounds or physical injuries or in response to a court order, warrant, subpoena or summons, or similar process authorized by law. We may also disclose PHI when the information is needed for identification or location of a suspect, fugitive, material witness or missing person, about a victim of a crime, about an individual who has died, in relation to criminal conduct on Trillium premises, or in emergency circumstances to report a crime, the location of the crime or victims, or the identity, description, or location of the person who committed the crime.
As required by law
Trillium must disclose Patient PHI if required to do so by federal, state, or local law.
Public Health
Trillium may disclose PHI for public health activities. These activities generally include:
- disclosures to a public health authority to report, prevent or control disease, injury, or disability;
- disclosures to report births and deaths, or to report child abuse or neglect;
- disclosures to a person subject to the jurisdiction of the Food and Drug Administration (FDA) for purposes related to the quality, safety or effectiveness of an FDA-regulated product or activity, including reporting reactions to medications or problems with products or notifying people of recalls of products they may be using;
- disclosures to notify a person who may have been exposed to a disease or may be at risk for contracting or spreading a disease or condition; and
- disclosures to an employer about an employee to conduct medical surveillance in certain limited circumstances concerning work-place illness or injury.
Disclosure about victims of abuse, neglect, or domestic violence
Trillium may disclose PHI about an individual to a government authority, including social services, if we reasonably believe that an individual is a victim of abuse, neglect, or domestic violence.
Health oversight activities
Trillium may disclose PHI to a health care oversight agency for activities authorized by law such as audits, civil, administrative, or criminal investigations and proceedings/actions, inspections, licensure/disciplinary actions, or other activities necessary for appropriate oversight of the health care system, government benefit programs, and compliance with regulatory requirements and civil rights laws.
Coroners, medical examiners, and funeral directors
Trillium may disclose PHI to a coroner, medical examiner, or funeral director for the purpose of identifying a deceased person, determining cause of death, or for performing some other duty authorized by law.
Organ and Tissue Donation
If requested, Trillium may disclose PHI to organizations that handle organ procurement, or eye and tissues donation banks, or other health care organization as needed to make organ and tissue donation and transplantation possible.
Personal Representative
Trillium may disclose PHI to a Patient personal representative, as established under applicable law, or to an administrator, executor, or other authorized individual associated with your estate.
Correctional institution
Trillium may disclose the PHI of an inmate or other individual when requested by a correctional institution or law enforcement official for health, safety, and security purposes.
Serious threat to health or safety
Trillium is allowed to disclose PHI when it has a good faith belief that the disclosure is necessary to prevent or lessen a serious and/or imminent threat to the health or safety of the patient or others and is to a person or persons reasonably able to prevent or lessen the threat.
Research
Trillium may use and disclose PHI for research purposes. Limited data or records may be viewed by researchers to identify patients who may qualify for their research project or for other similar purposes, so long as the researchers do not remove or copy any of the PHI. Before we use or disclose PHI for any other research activity, one of the following will happen a committee will determine that the research activity poses minimal risk to privacy and that there is an adequate plan to safeguard PHI, if the PHI relates to deceased individuals, the researchers give us assurances that the PHI is necessary for the research and will be used only as part of the research, or the researcher will be provided only with information that does not identify a Patient.
Government functions
In certain situations, Trillium may disclose the PHI of military personnel and veterans, including Armed Forces personnel, as required by military command authorities. Additionally, we may disclose PHI to authorized officials for national security purposes, such as protecting the President of the United States, conducting intelligence, counter-intelligence, other national security activities, and when requested by foreign military authorities. Disclosures will be made only in compliance with U.S. Law.
Workers’ compensation
As authorized by applicable laws, Trillium may use or disclose PHI to comply with workers’ compensation or other similar programs established to provide work-related injury or illness benefits.
De-identified Information and Limited Data Sets
Trillium may use and disclose health information that has been “de-identified” by removing certain identifiers making it unlikely that you could be identified.
Trillium also may disclose limited health information, contained in a “limited data set”. The limited data set does not contain any information that can directly identify Patient. For example, a limited data set may include your city, county and zip code, but not your name or street address.
Some of the uses and disclosures described above may be limited or restricted by state laws or other legal requirements, for example, the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”). Please contact our Privacy Officer, using the contact information provided at the end of this notice, for specific information regarding your state.
Other Uses and Disclosures of PHI
For purposes not described above, including uses and disclosures of PHI for marketing purposes and disclosures that would constitute a sale of PHI, Trillium will ask for patient authorization before using or disclosing PHI. If a Patient signed an authorization form, you may revoke it, in writing, at any time, except to the extent that action has been taken in reliance on the authorization.
Additional Safeguards and Protections
Trillium employs additional safeguards for PHI that are subject to protection under other federal and state laws, for example, relating to mental health, HIV/AIDS, and genetic testing. Additionally, federally assisted alcohol and drug treatment programs are subject to restrictions on the use and disclosure of alcohol and drug abuse treatment information. As applicable, Trillium will obtain your permission before disclosing the information to other health care providers who are not involved in your treatment program or care.
Information Breach Notification
Trillium is required to provide patient notification if it discovers a breach of unsecured PHI unless there is a
demonstration, based on a risk assessment, that there is a low probability that the PHI has been compromised. A Patient will be notified without unreasonable delay and no later than 60 days after discovery of the breach. Such notification will include information about what happened and what can be done to mitigate any harm.
Patient Rights Regarding PHI
Subject to certain exceptions, HIPAA establishes the following patient rights with respect to PHI:
Right to Receive a Copy of the Trillium Notice of Privacy Practices
You have a right to receive a copy of the Trillium Notice of Privacy Practices at any time by contacting us at info@TrilliumBiO.com, calling us at 1-888-262-2812 or by sending a written request to: HIPAA Privacy Officer, Trillium, 9808 Medical Center Drive, Suite 330, Rockville, MD 20850. This Notice will also be posted on the Trillium Internet site at www.Trillium-Health.com.
Right to Request Limits on Uses and Disclosures of your PHI
Patients each have the right to request that Trillium limit: 1) how we use and disclose Patient PHI for treatment, payment, and health care operations activities; or 2) our disclosure of PHI to individuals involved in Patient care or payment for Patient care. Trillium will consider Patient’s request but is not required to agree to it unless the requested restriction involves a disclosure that is not required by law to a health plan for payment or health care operations purposes and not for treatment, and Patient have paid for the service in full out of pocket. If we agree to a restriction on other types of disclosures, we will state the agreed restrictions in writing and will abide by them, except in emergency situations when the disclosure is for purposes of treatment.
Right to Request Confidential Communications
Each Patient has the right to request that Trillium communicate with you about your PHI at an alternative address or by an alternative means. Trillium will accommodate reasonable requests.
Right to See and Receive Copies of Patient PHI
Each Patient and their personal representative have the right to access PHI consisting of their laboratory test results or reports ordered by their physician.
Within 30 days after our receipt of request from the Patient, the Patient will receive a copy of the completed laboratory report from Trillium unless an exception applies. Exceptions include a determination by a licensed health care professional that the access requested is reasonably likely to endanger the life or safety of the Patient or another person, and our inability to provide access to the PHI within 30 days, in which case we may extend the response time for an additional 30 days if we provide the Patient with a written statement of the reasons for the delay and the date by which access will be provided. The Patient has the right to access and receive Patient PHI in an electronic format if it is readily producible in such a format. To request a copy of your PHI:
- Ask for a courtesy copy when a Patient visits a Trillium patient service center for specimen collection.
- Ask a Trillium patient service technician for information on how to open a Trillium patient portal account to receive your laboratory reports electronically.
- Complete the Trillium HIPAA Patient Request Form.
- Contact the Privacy Officer at 1-888-262-2812 or by e-mail at info@TrilliumBiO.com.
Right to Receive an Accounting of Disclosures
Each Patient shall have a right to receive a list of certain instances in which Trillium disclosed their PHI. This list will not include certain disclosures of PHI, such as (but not limited to) those made based on a Patient’s written authorization or those made prior to the date on which Trillium was required to comply. If a Patient requests an accounting of disclosures of PHI that were made for purposes other than treatment, payment, or health care operations, the list will include disclosures made in the past six years, unless a Patient requests a shorter period of disclosures. If a Patient requests an accounting of disclosures of PHI that were made for purposes of treatment, payment, or health care operations, the list will include only those disclosures made in the past three years for which an accounting is required by law, unless you request a shorter period of disclosures.
Right to Correct or Update your PHI
If a Patient believes that their PHI contains a mistake, the Patient may request, in writing, that Trillium correct the information. If the Patient’s request is denied,
Trillium will provide an explanation of the reasoning for denial.
How the Patient Exercises their Rights
To exercise any of the Patients’ rights described in this notice, Patient must send a written request to: HIPAA Privacy Officer, Trillium, 9808 Medical Center Drive, Suite 330, Rockville, MD 20850.
How to Contact Us or File a Complaint
If a Patient has questions or comments regarding the Trillium Notice of Privacy Practices, or have a complaint about our use or disclosure of your PHI or our privacy practices, please contact: info@TrilliumBiO.com, call us at 1- 888-262-2812 and ask for the Trillium HIPAA Privacy Officer, or send a written request to: HIPAA Privacy Officer, Trillium, 9808 Medical Center Drive, Suite 330, Rockville, MD 20850.
A Patient may file a complaint with the Secretary of the U.S. Department of Health and Human Services. Trillium will not take retaliatory action against a Patient for filing a complaint about our privacy practices.
Changes to the Trillium Notice of Privacy Practices
Trillium reserves the right to make changes to this notice and to our privacy policies from time to time. Changes adopted will apply to any PHI we maintain about the Patient. Trillium is required to abide by the terms of our notice currently in effect. When changes are made, we will promptly update this notice and post the information on the
Trillium website at www.Trillium-Health.com. Please review this site periodically to ensure that you are aware of any such updates.
Effective Date of Notice: April 1, 2023 Revised: January 13, 2025
HIPAA Contacts
Trillium works diligently to provide exceptional, quality service to all of its clients and is committed to implementing the Health Insurance Portability and Accountability Act of 1996 (HIPAA). The following information is provided to assist clients in contacting the appropriate Trillium office with questions regarding HIPAA.
HIPAA Inquiries
info@TrilliumBiO.com or call 1-888-261-2812
Terms of Use
TERMS OF USE
Trillium Health, LLC d/b/a TrilliumBiO (“Company,” “we”, “us” or “our”) maintains these Terms of Service (these “Terms”) that describe the terms and conditions applicable to and your use of our website (the “Site”) and any services made available on our website including the ability to order test kits or other materials (the “Service”). Your use of the Site and the Service is subject at all times to these Terms and our Privacy Policy (“Privacy Policy”), which is considered a part of these Terms. Any inconsistency between these Terms and the Privacy Policy shall be resolved by the Company in its sole and absolute discretion.
PLEASE READ THESE TERMS CAREFULLY BEFORE ACCESSING OR USING THE SITE OR THE SERVICE. BY ACCESSING OR USING THE SITE OR THE SERVICE, YOU WILL BE BOUND BY THESE TERMS.
1. THE SERVICE
(a) General Description. Through the Site and the Site and the Service, we offer information about the various testing and other solutions that we provide. Your use of any of the information is at your own and risk and subject to the terms and conditions set out in these Terms.
(b) No Medical or Professional Advice. Neither the Site nor the Site and the Service includes or represents the provision of medical advice by the Company. TrilliumBiO does not offer medical advice or diagnoses or engage in the practice of medicine or any other professional service. Information and materials provided to you by us through the Site and the Service are not intended to be, and do not constitute, a substitute for professional medical advice, diagnosis or treatment. Further, the Site and the Service does not provide professional coding or billing support and any recommendations should be reviewed by appropriate individuals. Users are responsible for utilizing their own professional training and seeking additional input as determined by each User.
(c) License to Use Service. Subject to these Terms and the Privacy Policy, the Company grants to you a limited, non-exclusive, non-transferable, non-sublicensable and revocable right and license to access and use the Site and the Site and the Service. The Company may terminate this license without notice in the event you fail to comply with these Terms or the Privacy Policy as determined by us in our sole discretion. Upon termination of the license, you must immediately cease accessing and using the Site and the Site and the Service. (d) Acceptance of These Terms. You affirm that you are at least 18 years of age or older and creating the Account for use in connection with an existing customer of TrilliumBiO. By accepting these Terms, you affirm that you are fully able and competent to enter into and
abide by all of the terms and conditions set forth in these Terms. The Service is not intended for use by any User under the age of 18 and if Company learns that an Account has been created by a User who is under the age of 18, then Company may immediately terminate such Account.
(e) Communications. As part of the Service, you will receive email and other communications from us relating to or deriving from your use of the Service. By disclosing your email and other contact information during the process of creating your Account, you acknowledge and authorize that we may send you such communications, including text messages if you provided your cellphone number. You will no longer receive communications contemplated by these Terms if you opt-out of receiving or unsubscribe from such communications in accordance with the procedures set forth in the Privacy Policy or the applicable communication.
If you provide your cellphone number, as stated above, you consent to receive text messages from us, about our Services. You may choose not to receive text messages even if you previously provided your cellphone number. Text and data rates from your mobile carrier may apply when you agree to receive text messages and you should check your mobile plan or with your carrier to confirm the rates if you have any questions. If necessary, we might share your cellphone number with a third party service solely to enable the sending of the text message. We will not share your cellphone number with a third party for marketing purposes without getting your consent first. If you no longer want to receive text messages, you can text STOP in response to any message or email us at Support@TrilliumBiO.com with a request to no longer receive text messages.
(f) Limitations. The license granted to you is subject to the following limitations. You shall not nor permit any other person to: (i) in whole or in part, (1) modify, translate or create any derivative work of the Site and the Service, including any Company Content (defined below) or (2) copy, photocopy, reproduce, translate, disassemble, reverse engineer, decompile, or otherwise attempt to derive source code, underlying ideas, algorithms, structure, or organization of the Site and the Service; (ii) modify, alter or remove any copyright, patent, confidentiality, trademark or other notices, labels or legends displayed in the Site and the Service, including in any Company Content; (iii) sell, grant a security interest in or transfer the Site and the Service or reproductions of any Company Content or any part of either the Site and the Service or Company Content for any purposes in any way not expressly authorized in these Terms; (iv) assign, rent, lease, distribute or license any Company Content or any part of the Site and the Service to others; or (v) exploit the Site and the Service, including any Company Content or any of its parts, for any commercial purpose.
2. IP OWNERSHIP
(a) Company Content. The Company shall retain exclusive right, title and interest (including all intellectual property rights) in and to the App, the Site, all materials that are part of the App or Site (including past, present, and future versions), including, without limitation: art, icons, graphics, layout, text, images, audio and/or video, designs, features, advertisements, logos, domain names, trade names and marks, and service marks, any and all copyrightable material, the “look and feel”, the compilation, assembly and arrangement of the materials of the Site and the Service, and all other materials or content made available in the Site and the Service (collectively, “Company Content”). All Company Content is protected from unauthorized use, copying, and dissemination by applicable copyright, trademark, patent, publicity and other laws, rules, regulations and international treaties.
(b) Trademarks. All words and logos in the Site and the Service marked by the ™ or ® symbols are trademarks and service marks of the Company. All rights are reserved by the Company. All other trademarks and service marks appearing in the Site and the Service are the property of their respective owners. All rights are reserved. Use of any of our trademarks, service marks or names as “metatags” for any purpose other than as expressly authorized in these Terms is strictly prohibited.
(c) No Additional Rights. Only those licenses expressly set forth in these Terms are granted. No other licenses are granted under these Terms, whether by implication, estoppel, course of conduct, or otherwise. Nothing in these Terms is intended to nor will these Terms transfer any of the right, title, or interest (including any intellectual property right) from the Company and/or its licensors to you or any third party. If you are ever inadvertently or erroneously held or deemed to be the owner of any such rights, you will assign, and hereby irrevocably assign, to the Company or its licensors, as the case may be, all such rights as of the effective date of these Terms, and will execute all documents to implement and confirm the terms and intent of this Section or designate the Company as your power of attorney to solely to effectuate such assignment.
3. CONDUCT
(a) You are personally responsible for your access and use of the Site and the Site and the Service and for any of your information that you may provide to us in your use of the Site or the Site and the Service. You will indemnify and hold harmless the Company, its licensors, suppliers, partners, affiliates and their respective employees, officers, directors and agents (collectively, “Company Affiliates”) from all claims for liabilities, losses and expenses, including reasonable attorneys’ fees and costs, from third parties arising from such use and activity. Specifically, you will comply with these Terms, all applicable laws, rules and regulations governing the disclosure and use of third party property, including, without
limitation, any and all intellectual property rights. Moreover, you will not engage in any of the following:
(i) Post, transmit, promote, distribute or provide links to illegal content;
(ii) Harass, threaten, abuse, disparage, libel, slander, embarrass, or engage in any other disruptive behavior involving another user;
(iii) Transmit or facilitate distribution of content that is harmful, abusive, racially or ethnically offensive, vulgar, sexually explicit, defamatory, infringing, invasive of personal privacy or publicity rights, or in a reasonable person’s view, objectionable;
(iv) Infringe upon the intellectual property rights of the Company or any third party;
(v) Alter, delete or cancel any other user’s profile information or User Content;
(vi) Disrupt the flow communication areas within the Site and the Service with vulgar language, abusiveness, hitting the return key repeatedly or inputting large images so the screen goes by too fast to read, use of excessive shouting, using ALL CAPS in an attempt to disturb other users, “spamming” or flooding or posting repetitive text;
(vii) Impersonate another person, indicate that you are a Company Affiliate, or attempt to mislead users by indicating that you represent Company or any Company Affiliate;
(viii) Use any robot, spider, scraper, or other automated means (other than in accordance with these Terms and any additional terms) to access the Site and the Service for any purpose without our express written permission or bypass measures we may use to prevent or restrict access to the Site and the Service;
(ix) Attempt to get a user ID, password, or other user information, or any other private information from a user. TrilliumBiO employees will NEVER ask for your password. DO NOT give your password or secret answers out to anyone;
(x) Upload any content, including User Content that you do not own or have the right use and/or license to the Company in accordance with these Terms;
(xi) Engage in or promote or encourage any illegal or fraudulent activity including hacking, cracking or distribution of counterfeit software, or identity theft;
(xii) Upload User Content or display URLs that contain harmful or malicious code or corrupted data;
(xiii) Post messages for any purpose other than personal communication, including, without limitation, advertising, promotional materials, chain letters, direct marketing, multi-level marketing programs and pyramid schemes;
(xiv) Make any commercial use of the Site and the Service;
(xv) Improperly use support or complaint buttons or make false reports to Company;
(xvi) Use or distribute “auto” software programs, “macro” software programs or other “cheat utility” software program or applications;
(xvii) Modify, reproduce, distribute, delete or create derivative works of the Site and the Service, Company Content or any other users’ User Content displayed in the Site and the Service, or any component of such data or information;
(xviii) Solicit or attempt to solicit, and post, distribute or communicate any user’s personal information;
(xix) Interfere with, hack into or decipher any transmissions to or from the servers running the Site and the Service;
(xx) Exploit any bug in the Site and the Service or in any Company product to exploit it for commercial purposes. You will not communicate the existence of any such bug (either directly or through the public posting) to any other user or third party but will use reasonable efforts to report to us;
(xxi) Do anything that interferes with the ability of other users to enjoy the Site and the Service or that materially increases the expense or difficulty of Company in maintaining the Site and the Service for the enjoyment of all its users;
(xxii) Interfere or attempt to interfere with the proper functioning of the Site and the Service or connect to or use the Site and the Service in any way not expressly permitted by these Terms, including, without limitation, gain unauthorized access to any Company Content and other users’ User Content;
(xxiii) Use the Site and the Service in violation of these Terms, the Privacy Policy, or any applicable laws, rules or regulations, or do anything that promotes the violation of any applicable laws, rules or regulations; or
(xxiv) Engage in any other conduct which the Company, in its sole and absolute discretion, deems to violate these Terms.
4. THIRD PARTY CONNECTIONS
If applicable, in using the Site and the Service, you consent to the disclosure and use of all of your information collected by us to any third party component that Company incorporates into the Site and the Service, provided that Company will have appropriate agreements in place with such third parties, and any other third party that you identify, subject to Company’s ability to reasonably interface with such third party. You are solely responsible for all User Content and acknowledge that Company cannot and does not oversee how the Sponsor or any other third party that you authorize uses your User Content or interacts with you. You are solely responsible for any act or omission that you take in response to any interaction with a third party.
5. CHANGES TO TERMS
The Company may, from time to time, modify, amend, or supplement these Terms and post the updated Terms on the Site, provided that the Company will use reasonable efforts to post notice of the changes. Such modifications or supplements shall be effective immediately upon posting on the Site, whether or not notice has been posted. You are responsible for periodically checking the Site for changes to the Terms. You can determine when the Terms were last revised by referring to the “Effective Date” legend at the bottom of these Terms. If you do not agree to be bound by (or cannot comply with) the Terms as modified or supplemented, you should stop using the Site and the Service. Your continued access and use of the Site and the Service constitutes your agreement to be bound by the Terms as modified.
6. DISCLAIMER OF WARRANTIES
YOU EXPRESSLY AGREE THAT THE USE OF THE SITE, THE SERVICE, AND INTERNET ARE AT YOUR SOLE RISK. THE SITE AND THE SERVICE ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS FOR YOUR USE, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF MERCHANTABILITY, SATISFACTORY QUALITY, NON- INFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW. THE COMPANY PROVIDES THE SITE AND THE SERVICE ON A COMMERCIALLY REASONABLE BASIS AND DOES NOT GUARANTEE THAT YOU WILL BE ABLE TO ACCESS OR USE THE SITE OR THE SERVICE AT TIMES OR LOCATIONS OF YOUR CHOOSING, OR THAT THE COMPANY WILL HAVE ADEQUATE CAPACITY FOR THE SERVICE AS A WHOLE OR IN ANY SPECIFIC GEOGRAPHIC AREA. YOUR ACCESS AND USE OF THE SITE AND THE SERVICE IS AT YOUR OWN DISCRETION AND RISK AND YOU ARE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER OR MOBILE DEVICE, LOSS OF DATA OR ANY OTHER DAMAGES OR LOSSES THAT RESULT (DIRECTLY OR INDIRECTLY) FROM SUCH ACCESS OR USE. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES OR LIMITATIONS ON APPLICABLE STATUTORY RIGHTS, SO THE ABOVE EXCLUSION AND LIMITATIONS MAY NOT APPLY TO YOU.
7. LIMITATIONS OF LIABILITY
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, YOU ACKNOWLEDGE AND AGREE THAT, IN NO CASE SHALL COMPANY’S OR ANY OF COMPANY’S AFFILIATE’S LIABILITY TO YOU IN RESPECT TO ANY ACT OR FAILURE TO ACT IN RELATION TO THE SITE OR THE SERVICE EXCEED THE HIGHER OF US$100 OR THE AMOUNT PAID BY YOU IN CONNECTION WITH YOUR USE OF THE SITE OR THE SERVICE. FURTHERMORE, IN NO CASE SHALL THE COMPANY OR THE COMPANY AFFILIATES BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE DAMAGES (INCLUDING, WITHOUT LIMITATION, THOSE RESULTING FROM PERSONAL INJURY, DAMAGE TO PROPERTY, LOSS OF PROFITS, DATA, USE, GOODWILL, BUSINESS INTERRUPTION, OR OTHER COMPARABLE LOSS) ARISING FROM YOUR ACCESS AND USE OF THE SITE OR THE SERVICE, WHETHER BASED ON WARRANTY, PRODUCT LIABILITY, PERSONAL INJURY, CONTRACT, TORT OR ANY OTHER LEGAL THEORY AND WHETHER OR NOT THE COMPANY OR ANY COMPANY AFFILIATE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. BECAUSE SOME JURISDICTIONS DO NOT ALLOW THE FOREGOING EXCLUSION OR THE LIMITATIONS OF LIABILITY FOR CERTAIN DAMAGES, IN SUCH JURISDICTIONS, THE COMPANY’S AND COMPANY AFFILIATES’ LIABILITY SHALL BE LIMITED TO THE FULL EXTENT PERMITTED BY APPLICABLE LAW. THE COMPANY DOES NOT ENDORSE, WARRANT OR GUARANTEE ANY THIRD PARTY PRODUCT OR SERVICE OFFERED THROUGH THE SITE OR THE SERVICE AND WILL NOT BE A PARTY TO OR IN ANY WAY BE RESPONSIBLE FOR MONITORING ANY TRANSACTION BETWEEN YOU AND THIRD-PARTY PROVIDERS OF PRODUCTS OR SERVICES. SPECIFICALLY, WE ARE NO LIABLE TO YOU FOR ANY DAMAGE CAUSED BY THE ACTIONS OF ANY MEDICAL PROFESSIONAL OR ANY OTHER THIRD PARTY.
8. LINKS
For the convenience of our users, the Site and the Service may provide certain links to other applications, services and websites provided by third parties. The Company is not responsible for the content of any other applications, services or websites linked to or from the Site and the Service. If you follow any such links, you leave the Site and the Service and you do so entirely at your own risk. The Company provides links from the Site and the Service solely as a convenience to you and in no way should this be interpreted as a referral or endorsement of any content, sponsor or owner of any other applications, services and/or websites. THE COMPANY DISCLAIMS ALL WARRANTIES, RESPONSIBILITIES, LIABILITIES, CONDITIONS OR OTHER TERMS EXPRESS OR IMPLIED AS TO ANY SUCH LINKED WEBSITE, INCLUDING, WITHOUT LIMITATION, AS TO ACCURACY, OWNERSHIP, VALIDITY OR LEGALITY OF ANY CONTENT OF A LINKED APPLICATIONS, SERVICES OR WEBSITES, AND FOR ANY OF YOUR INFORMATION COLLECTED OR USED BY ANY SUCH THIRD PARTIES.
9. GOVERNING LAW
The laws of the State of Maryland and the United States of America, without regard to conflicts of law provisions, will apply to all matters arising out of or in connection with the Site and the Service and your access and use of the Site and the Service. By accessing and using the Site and the Service, you submit and consent to the exclusive jurisdiction of state and federal courts located in Montgomery County, Maryland with respect to any dispute or cause of action (whether contractual or non-contractual) arising out of or in connection with these Terms, the Privacy Policy, and/or your access and use of the Site and the Service. In any action or proceeding to enforce the rights under these Terms, the prevailing party shall be entitled to recover their reasonable attorneys’ fees and costs.
10. INJUNCTIVE RELIEF
You acknowledge that the rights granted and obligations made under these Terms to the Company are of a unique and irreplaceable nature, the loss of which shall irreparably harm the Company and cannot be replaced by monetary damages alone. To account for the inability of monetary damages to make the Company whole, the Company shall be entitled to injunctive or other equitable relief (without the obligations of posting any bond or surety) in the event of any breach or anticipatory breach of by you. To the fullest extent permitted under applicable law, you irrevocably waive all rights to seek injunctive or other equitable relief and agree to limit your claims to claims for money damages (if any).
11. VOID WHERE PROHIBITED
The information provided through the Site and the Service is not intended for distribution to or use by any person in any jurisdiction or country where such distribution or use would be contrary to law or regulation or that would subject the Company to any registration requirement within such jurisdiction or country. The Company makes no representation or warranty that any material in the Site and the Service is lawful in every jurisdiction from which such content can be accessed, or is available for use in all jurisdictions. THE SITE AND SERVICE ARE INTENDED FOR USE BY PERSONS AGE 18 OR OLDER. BY ACCESSING AND USING THE SITE OR THE SERVICE, YOU REPRESENT AND WARRANT THAT YOU ARE 18 OR OLDER, AND THAT YOU AGREE TO AND TO ABIDE BY ALL OF THE TERMS AND CONDITIONS OF THESE TERMS, THE PRIVACY POLICY AND ADDITIONAL TERMS. EXCEPT AS OTHERWISE STATED IN THESE TERMS, IF YOU ARE UNDER THE AGE OF 18, THE COMPANY MAY IMMEDIATELY (WITHOUT NOTICE) TERMINATE THE LICENSES GRANTED UNDER THESE TERMS AND CANCEL YOUR ACCOUNT.
12. PRIVACY POLICY
The Company is committed to respecting your privacy and the confidentiality of your User Content. The Privacy Policy sets out additional terms on how the Company may collect, use, share and store your User Content and other information. If you object to your User Content or other information being used in the way set out in the Privacy Policy, you should not access or use the Site and the Service.
13. DIGITAL MILLENNIUM COPYRIGHT ACT POLICY
We respect everyone’s intellectual property rights and do not want to misuse anyone else’s intellectual property. If you have a good faith belief that your intellectual property rights or the intellectual property rights of a third party have been violated and you would like us to remove, edit, or disable that content, please contact us and provide the following required information: (i) a description of the copyrighted work or other materials that you claim are being infringed, (ii) a description of the work or materials that you claim are infringing and needs to be removed, including where that work or material can be found, (iii) your address, telephone number, and email address so our Copyright Agent can contact you about the complaint, and (iv) a signed statement that the information you submitted is accurate, that you have a good faith belief that use of the identified work or material is not authorized by the copyright owner or its agents, and affirmation under the penalty of perjury that you are the copyright owner or authorized to act on behalf of the copyright owner. We will work to respond to each properly submitted complaint as quickly as we can, which response will include removing or disabling access to the work or material, if infringing. Please understand that you may be subject to penalties if you submit a false claim.
Please submit you notice in physical form or by email to TrilliumBiO’s Copyright Agent using the following contact information:
TrilliumBiO
9808 Medical Center Drive
Suite 300
Rockville, MD 20850
Attn: Quality Assurance
Support@TrilliumBiO.com
14. NO CLASS ACTIONS
YOU AND THE COMPANY AGREE THAT EACH MAY BRING CLAIMS AGAINST THE OTHER ONLY IN YOUR OR ITS INDIVIDUAL CAPACITY AND NOT AS A PLAINTIFF OR CLASS MEMBER IN ANY PURPORTED CLASS OR REPRESENTATIVE PROCEEDING. Further, unless both you and the Company agree otherwise, no court or other independent arbiter may consolidate more than one person’s claims, and may not otherwise preside over any form of a representative or class proceeding.
15. MISCELLANEOUS
If any provision of these Terms or the Privacy Policy is held to be invalid or unenforceable, that provision will be deemed to be restated to reflect as nearly as possible the original intention in accordance with applicable law, and the remainder of the Terms and/or Privacy Policy will remain in full force and effect. These Terms and the Privacy Policy constitute the entire agreement between us with respect to the subject matter of these Terms and Privacy Policy and supersede and replace all prior or contemporaneous understandings or agreements, written or oral, regarding such subject matter. Any waiver of any provision of these Terms will be effective only if in writing and signed by the Company. The failure of either party to assert any right under these Terms shall not be considered a waiver of that party’s right and the Terms will remain in full force and effect. In addition, these Terms and the Privacy Policy, including the Company’s enforcement of those policies, are not intended to confer, and do not confer, any rights or remedies upon any third party. You are not allowed to assign these Terms or any rights under these Terms. The Company is allowed at its sole discretion to assign these Terms or any rights under these Terms to any third party, without giving prior notice to you. Our licensors may be entitled to enforce these Terms. There are no other third party beneficiaries to these Terms.
If you have any questions, complaints, or comments regarding these Terms, or have other questions or suggestions about the Site and the Service, please email us at Support@TrilliumBiO.com.
Effective Date: August 4, 2025
Revised: May 11, 2026
Testing is performed by TrilliumBiO, a CLIA-certified, CAP-accredited, ISO 15189-accredited clinical laboratory. Use of these tests and their results should not replace independent clinical judgment. The healthcare professional, in consultation with the patient, should consider all potential management options.
1. World Health Organization. Dementia. Accessed July 28, 2026. https://www.who.int/news-room/fact-sheets/detail/dementia 2. Jack CR Jr, et al. Lancet Neurol. 2010;9(1):119-128. doi:10.1016/S1474-4422(09)70299-6 3. Jack CR Jr, et al. NIA-AA Research Framework: Toward a Biological Definition of Alzheimer’s Disease. Alzheimer’s Dementia. 2018;14(4):535-562. doi:10.1016/j.jalz.2018.02.018 4. Rabinovici GD, et al. JAMA. 2019;321(13):1286-1294. doi:10.1001/jama.2019.2000 5. Cognat E, et al. BMJ Open. 2019;9(5): e026380. doi:10.1136/bmjopen-2018-026380 6. Quest Diagnostics. The Coming Alzheimer’s Disease Healthcare Revolution: US Physician and Adult Perspectives on the Future of Diagnostics and Treatment. May 2022 7. Alzheimer’s Association. 2026 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dementia. 2026. Accessed July 2026 8. Baylor College of Medicine. The ethics of telling an Alzheimer’s diagnosis and the power of communication. April 2025 9. Chun MY, et al. Cognitive Stage–Adapted Amyloid PET Thresholds for Plasma p-tau217 Testing. AAIC 2026; July 12–15, 2026; London, UK 10. Wilson D, et al. Multi-Analyte Plasma Risk Score Improves Sensitivity and Certainty for Early AD Detection in a Diverse Community-Based Cohort. AAIC 2026; July 12–15, 2026; London, UK 11. Chabrashvili T, Qasim S. Real-World Concordance of Blood-Based Biomarkers with CSF or PET in Suspected Alzheimer’s Disease. AAIC 2026; July 12–15, 2026; London, UK 12. Nair K, et al. Blood-Based Biomarkers in Early Alzheimer’s Disease: Real-World Adoption Trends and the Transformation of Diagnostic Pathways. AAIC 2026; July 12–15, 2026; London, UK 13. Li C, et al. Real-world Diagnostic Performance of Plasma P-tau217 in Memory Clinics: A Multicenter Study From Northwest China. AAIC 2026; July 12–15, 2026; London, UK 14. Giuffrè GM, et al. Real-world Diagnostic and Prognostic Performance of Plasma Biomarkers for Alzheimer’s Disease in a Mild Cognitive Impairment Cohort. AAIC 2026; July 12–15, 2026; London, UK 15. Lai Y, et al. Cognitive Function and Plasma Biomarkers Dynamics in Alzheimer’s Disease During Lecanemab Treatment: A Real-World Clinical Study. AAIC 2026; July 12–15, 2026; London, UK 16. Burns JM, et al. JAMA Neurology. 2026;83(6):515. DOI: 10.1001/jamaneurol.2026.0801
